Yakob Liawatidewi - 08 Aug 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
EVP Corp Admin Center
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
08 Aug 2022
Net transactions value
-$149,737
Form type
4
Filing time
10 Aug 2022, 17:04:48 UTC
Previous filing
18 Jul 2022
Next filing
08 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $98,950 +5,000 +8.1% $19.79 66,607 08 Aug 2022 Direct
transaction AMPH Common Stock Sale $190,000 -5,000 -7.5% $38.00 61,607 08 Aug 2022 Direct F1
transaction AMPH Common Stock Options Exercise $60,458 +3,055 +5% $19.79 64,662 09 Aug 2022 Direct
transaction AMPH Common Stock Sale $119,145 -3,055 -4.7% $39.00 61,607 09 Aug 2022 Direct F1
holding AMPH Common Stock 2,459 08 Aug 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -5,000 -62% $0.000000 3,055 08 Aug 2022 Common Stock 5,000 $19.79 Direct F3
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -3,055 -100% $0.000000* 0 09 Aug 2022 Common Stock 3,055 $19.79 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2022.
F2 The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
F3 Shares subject to the option are fully vested and immediately exercisable.